Publications by authors named "Xiaqin Cheng"

Claim this Profile
O
Overall survival according to time-of-day of combined immuno-chemotherapy for advanced gastric cancer: a propensity score-matched analysis.
Chong Cheng, Xiaqin Cheng, Tiejun Wang

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel secondary ALK gene mutation which resistant to second-generation TKIs: a case report and literature review.
Xiaqin Cheng, Jia Liu, Qiongxia Hu, Yingchun Gao, Lin Zhou

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going from 3D/3D to 2D/3D registration for noncoplanar setup verification in intracranial single-isocenter multiple-target hypofractionated stereotactic radiotherapy: comparison between kilo-voltage/mega-voltage image pairs and noncoplanar cone-beam computed tomography.
Jialu Lai, Shoupeng Liu, Jia Liu, Maoyue Fu, Maoqiong Jiang, Xiaqin Cheng

Quant Imaging Med Surg· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
Fu-Xue Huang, Jun-Wan Wu, Xia-Qin Cheng, Jiu-Hong Wang, Xi-Zhi Wen

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer.
Wei Wei, Xiaohua Ban, Fan Yang, Jibin Li, Xiaqin Cheng

J Immunother Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis